AstraZeneca PLC (BCBA:AZN)
Argentina flag Argentina · Delayed Price · Currency is ARS
74,650
-1,625 (-2.13%)
Last updated: Mar 2, 2026, 3:06 PM BRT

AstraZeneca Ratios and Metrics

Millions ARS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
444,017,623417,731,863209,469,693169,189,47037,097,13818,693,290
Market Cap Growth
83.83%99.42%23.81%356.07%98.45%69.36%
Enterprise Value
477,539,484453,426,251235,248,695189,832,62942,224,84421,515,860
Last Close Price
75000.0069837.9337903.5231329.2110931.675573.19
PE Ratio
29.9228.1528.8835.1463.701625.31
PS Ratio
5.214.903.764.574.724.87
PB Ratio
6.285.914.975.345.654.63
P/FCF Ratio
26.0024.4620.4523.2924.0337.36
P/OCF Ratio
20.9919.7517.1320.2321.3530.53
EV/Sales Ratio
5.835.324.225.135.385.60
EV/EBITDA Ratio
17.4016.0412.9916.5117.3531.27
EV/EBIT Ratio
23.9722.7317.6524.3427.0572.32
EV/FCF Ratio
27.9726.5522.9626.1427.3543.01
Debt / Equity Ratio
0.610.610.750.760.840.85
Debt / EBITDA Ratio
1.531.531.702.042.234.81
Debt / FCF Ratio
2.532.533.073.303.576.85
Net Debt / Equity Ratio
0.490.490.610.610.670.69
Net Debt / EBITDA Ratio
1.231.231.421.671.814.02
Net Debt / FCF Ratio
2.042.042.512.652.865.54
Asset Turnover
0.540.540.530.460.440.44
Inventory Turnover
1.801.801.801.591.261.85
Quick Ratio
0.720.720.670.580.620.67
Current Ratio
0.940.940.930.820.861.16
Return on Equity (ROE)
22.84%22.84%17.59%15.64%8.63%0.42%
Return on Assets (ROA)
7.88%7.88%7.88%6.10%5.46%2.10%
Return on Invested Capital (ROIC)
15.85%16.38%16.27%13.35%13.75%6.00%
Return on Capital Employed (ROCE)
16.50%16.50%17.00%13.70%12.60%3.50%
Earnings Yield
3.34%3.55%3.46%2.85%1.57%0.06%
FCF Yield
3.85%4.09%4.89%4.29%4.16%2.68%
Dividend Yield
1.38%-8.43%7.48%4.70%5.29%
Payout Ratio
47.39%48.62%65.80%75.25%132.72%3442.86%
Buyback Yield / Dilution
0.06%0.06%-0.06%-0.13%-9.32%-8.68%
Total Shareholder Return
1.45%0.06%8.37%7.36%-4.62%-3.39%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.